Sunny Song, PhD, MBA

Head of New Therapeutics Global BD&L at Samyang Biopharm

Speaker

Sunny Song, PhD, MBA is a global business development, licensing, and strategic partnership leader with over 20 years of experience across biotech, pharma, and techbio. She has held senior roles at Fortune 500 R&D including Thermo Fisher, Danaher, and Agilent, as well as global GMP CDMO business development at WuXi Biologics, driving multimillion-dollar contracts and strategic alliances. Sunny has a strong track record in early-stage startup funding, business development, and international partnerships across the U.S., China, India, and Korea. She currently serves as Head of Global Business Development and Licensing for New Therapeutics at Samyang Biopharm Corp. and Samyang Biopharm USA, part of Samyang Group family (Korean conglomerate, $4B revenue) advancing growth through licensing, collaborations, and innovation-driven strategic partnerships.